| Ethical issues of CRISPR technology and gene editing through the lens of solidarity JJ Mulvihill, B Capps, Y Joly, T Lysaght, HAE Zwart, R Chadwick, ... British medical bulletin 122 (1), 17-29, 2017 | 99* | 2017 |
| Informed consent for human genetic and genomic studies: a systematic review A Khan, BJ Capps, MY Sum, CN Kuswanto, K Sim Clinical genetics 86 (3), 199-206, 2014 | 46 | 2014 |
| Ethical and regulatory challenges with autologous adult stem cells: a comparative review of international regulations T Lysaght, IH Kerridge, D Sipp, G Porter, BJ Capps Journal of Bioethical Inquiry 14, 261-273, 2017 | 36 | 2017 |
| Justice is the missing link in one health: results of a mixed methods study in an urban city state T Lysaght, B Capps, M Bailey, D Bickford, R Coker, Z Lederman, ... PLoS One 12 (1), e0170967, 2017 | 36 | 2017 |
| One health, vaccines and ebola: the opportunities for shared benefits B Capps, Z Lederman Journal of Agricultural and Environmental Ethics 28, 1011-1032, 2015 | 34 | 2015 |
| Addiction neurobiology: Ethical and social implications A Carter, B Capps, W Hall European Monitoring Centre for Drugs and Drug Addiction, 2009 | 34* | 2009 |
| One Health and paradigms of public biobanking B Capps, Z Lederman Journal of Medical Ethics 41 (3), 258-262, 2015 | 33 | 2015 |
| Introducing One Health to the Ethical Debate About Zoonotic Diseases in S outheast Asia B Capps, MM Bailey, D Bickford, R Coker, Z Lederman, A Lover, ... Bioethics 29 (8), 588-596, 2015 | 31 | 2015 |
| Oversight for clinical uses of autologous adult stem cells: lessons from international regulations T Lysaght, I Kerridge, D Sipp, G Porter, BJ Capps Cell Stem Cell 13 (6), 647-651, 2013 | 30 | 2013 |
| Influenza pandemic and the duties of healthcare professionals TC Voo, B Capps Singapore Med J 51 (4), 275-281, 2010 | 28 | 2010 |
| Falling giants and the rise of gene editing: ethics, private interests and the public good B Capps, R Chadwick, Y Joly, JJ Mulvihill, T Lysaght, H Zwart Human Genomics 11, 1-10, 2017 | 26 | 2017 |
| Ethical principles for the use of human cellular biotechnologies PR Wolpe, KS Rommelfanger, ... Nature Biotechnology 35 (11), 1050-1058, 2017 | 26 | 2017 |
| Expect the unexpected: screening for secondary findings in clinical genomics research MP Mackley, B Capps British Medical Bulletin 122 (1), 109-122, 2017 | 23 | 2017 |
| Authoritative regulation and the stem cell debate B Capps Bioethics 22 (1), 43-55, 2008 | 22 | 2008 |
| Where does open science lead us during a pandemic? A public good argument to prioritize rights in the open commons B Capps Cambridge Quarterly of Healthcare Ethics 30 (1), 11-24, 2021 | 21 | 2021 |
| The use of depot naltrexone under legal coercion: the case for caution W Hall, B Capps, A Carter Addiction 103 (12), 1922-1924, 2008 | 21 | 2008 |
| Do chimeras have minds?: The ethics of clinical research on a human–animal brain model B Capps Cambridge Quarterly of Healthcare Ethics 26 (4), 577-591, 2017 | 19 | 2017 |
| The public interest, public goods, and third-party access to UK Biobank B Capps Public Health Ethics 5 (3), 240-251, 2012 | 19 | 2012 |
| Therapeutic misconception in psychiatry research: a systematic review ISK Thong, MY Foo, MY Sum, B Capps, TS Lee, C Ho, K Sim Clinical Psychopharmacology and Neuroscience 14 (1), 17, 2016 | 18 | 2016 |
| Libertarianism, legitimation, and the problems of regulating cognition-enhancing drugs B Capps Neuroethics 4 (2), 119-128, 2011 | 18 | 2011 |
